GB8310477D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB8310477D0
GB8310477D0 GB838310477A GB8310477A GB8310477D0 GB 8310477 D0 GB8310477 D0 GB 8310477D0 GB 838310477 A GB838310477 A GB 838310477A GB 8310477 A GB8310477 A GB 8310477A GB 8310477 D0 GB8310477 D0 GB 8310477D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB838310477A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB838310477A priority Critical patent/GB8310477D0/en
Publication of GB8310477D0 publication Critical patent/GB8310477D0/en
Priority to ZA842875A priority patent/ZA842875B/xx
Priority to ZW65/84A priority patent/ZW6584A1/xx
Priority to AT0129184A priority patent/AT390611B/de
Priority to SE8402188A priority patent/SE462594B/sv
Priority to LU85329A priority patent/LU85329A1/fr
Priority to NZ221999A priority patent/NZ221999A/xx
Priority to IE965/84A priority patent/IE57237B1/en
Priority to NZ207885A priority patent/NZ207885A/xx
Priority to CA000452288A priority patent/CA1335999C/en
Priority to DE3448338A priority patent/DE3448338C2/de
Priority to PH30586A priority patent/PH21574A/en
Priority to ES531722A priority patent/ES8505641A1/es
Priority to DE3448452A priority patent/DE3448452C2/de
Priority to AU27064/84A priority patent/AU573212B2/en
Priority to IL71569A priority patent/IL71569A/xx
Priority to NO841568A priority patent/NO159016C/no
Priority to LU88265C priority patent/LU88265I2/xx
Priority to DE19843414752 priority patent/DE3414752A1/de
Priority to FR8406115A priority patent/FR2545482B1/fr
Priority to BE0/212786A priority patent/BE899448A/fr
Priority to GB08410124A priority patent/GB2140800B/en
Priority to DE1995175029 priority patent/DE19575029I2/de
Priority to AR84296363A priority patent/AR244199A1/es
Priority to FI841548A priority patent/FI85011C/fi
Priority to JP59078275A priority patent/JPS59199659A/ja
Priority to PT78443A priority patent/PT78443B/pt
Priority to CH4750/86A priority patent/CH667084A5/fr
Priority to CH1977/84A priority patent/CH661497A5/fr
Priority to DK201784A priority patent/DK167493B1/da
Priority to HU841498A priority patent/HU200160B/hu
Priority to GR74450A priority patent/GR79925B/el
Priority to IT48064/84A priority patent/IT1199112B/it
Priority to KR1019840002030A priority patent/KR920004186B1/ko
Priority to NLAANVRAGE8401258,A priority patent/NL188406C/xx
Priority to BE0/213843A priority patent/BE900835R/fr
Priority to ES539625A priority patent/ES8609209A1/es
Priority to GB08612357A priority patent/GB2176476B/en
Priority to AR87306841A priority patent/AR245687A1/es
Priority to MYPI87002277A priority patent/MY102087A/en
Priority to JP63043277A priority patent/JPS63264443A/ja
Priority to AR89313169A priority patent/AR247721A1/es
Priority to KE3864A priority patent/KE3864A/xx
Priority to SG122/89A priority patent/SG12289G/en
Priority to HK368/89A priority patent/HK36889A/xx
Priority to US07/397,664 priority patent/US4992474A/en
Priority to CY1482A priority patent/CY1482A/xx
Priority to US07/541,631 priority patent/US5091422A/en
Priority to US07/619,899 priority patent/US5126375A/en
Priority to US07/810,183 priority patent/US5243076A/en
Priority to SK4028-91A priority patent/SK278120B6/sk
Priority to CS914028A priority patent/CZ285602B6/cs
Priority to US07/837,783 priority patent/US5225445A/en
Priority to MX9203226A priority patent/MX9203226A/es
Priority to CA000616467A priority patent/CA1336004C/en
Priority to JP4219484A priority patent/JPH0729997B2/ja
Priority to DK199201580A priority patent/DK175083B1/da
Priority to NL930066C priority patent/NL930066I2/nl
Priority to BG98059A priority patent/BG61490B2/bg
Priority to EC1994001094A priority patent/ECSP941094A/es
Priority to NO1994017C priority patent/NO1994017I1/no
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1742Unsaturated ethers containing halogen containing six-membered aromatic rings with halogen atoms bound to the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/20Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB838310477A 1983-04-18 1983-04-18 Chemical compounds Pending GB8310477D0 (en)

Priority Applications (61)

Application Number Priority Date Filing Date Title
GB838310477A GB8310477D0 (en) 1983-04-18 1983-04-18 Chemical compounds
ZA842875A ZA842875B (en) 1983-04-18 1984-04-17 Phenethanolamine derivatives
ZW65/84A ZW6584A1 (en) 1983-04-18 1984-04-17 Phenethanolamine derivatives
AT0129184A AT390611B (de) 1983-04-18 1984-04-18 Verfahren zur herstellung von neuen phenaethanolaminverbindungen und ihren salzen und solvaten
SE8402188A SE462594B (sv) 1983-04-18 1984-04-18 Fenetanolaminderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner
LU85329A LU85329A1 (fr) 1983-04-18 1984-04-18 Derives de phenethanolamine
NZ221999A NZ221999A (en) 1983-04-18 1984-04-18 Phenylalkoxy derivatives
IE965/84A IE57237B1 (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives
NZ207885A NZ207885A (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives and pharmaceutical compositions
CA000452288A CA1335999C (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives
DE3448338A DE3448338C2 (ja) 1983-04-18 1984-04-18
PH30586A PH21574A (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives
ES531722A ES8505641A1 (es) 1983-04-18 1984-04-18 Un procedimiento para la preparacion de derivados de fenetanolamina.
DE3448452A DE3448452C2 (de) 1983-04-18 1984-04-18 Phenylalkoxyalkylaminderivate und ihre Verwendung
AU27064/84A AU573212B2 (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives
IL71569A IL71569A (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives,their preparation and pharmaceutical compositions containing them
NO841568A NO159016C (no) 1983-04-18 1984-04-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
LU88265C LU88265I2 (ja) 1983-04-18 1984-04-18
DE19843414752 DE3414752A1 (de) 1983-04-18 1984-04-18 Phenethanolamin-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR8406115A FR2545482B1 (fr) 1983-04-18 1984-04-18 Derives de phenethanolamine
BE0/212786A BE899448A (fr) 1983-04-18 1984-04-18 Derives de phenethanol-amine.
GB08410124A GB2140800B (en) 1983-04-18 1984-04-18 Phenethanolamine derivatives
DE1995175029 DE19575029I2 (de) 1983-04-18 1984-04-18 4-Hydroxy-1-ÄÄÄ6-(4-phenylbutoxy)-hexalÜ-aminoÜ-methylÜ-1,3-benzoldimenthanol und seine physiologisch annehmbaren Salze
AR84296363A AR244199A1 (es) 1983-04-18 1984-04-18 Procedimiento para preparar derivados de fenetanolamina y sus sales y solvatos farmaceuticamente aceptables.
FI841548A FI85011C (fi) 1983-04-18 1984-04-18 Foerfarande foer framstaellning av farmakologiskt vaerdefulla fenetanolaminderivat.
JP59078275A JPS59199659A (ja) 1983-04-18 1984-04-18 フエネタノ−ルアミン誘導体
PT78443A PT78443B (en) 1983-04-18 1984-04-18 Process for preparing phenethanolamine derivatives
CH4750/86A CH667084A5 (fr) 1983-04-18 1984-04-18 Composes phenylalkoxy.
CH1977/84A CH661497A5 (fr) 1983-04-18 1984-04-18 Composes de phenethanolamine.
DK201784A DK167493B1 (da) 1983-04-18 1984-04-18 Phenethanolaminderivater og fysiologisk acceptable syreadditionssalte og solvater deraf og et farmaceutisk praeparat deraf
HU841498A HU200160B (en) 1983-04-18 1984-04-18 Process for producing phenethanolamine derivatives and pharmaceutical compositions comprising same as active ingredient
GR74450A GR79925B (ja) 1983-04-18 1984-04-18
IT48064/84A IT1199112B (it) 1983-04-18 1984-04-18 Derivati di fenetanolammina dotati di azione stimolante al livello dei beta 2-adrenoricettori,e procedimento per la loro preparazione
KR1019840002030A KR920004186B1 (ko) 1983-04-18 1984-04-18 펜에탄올아민 유도체의 제조방법
NLAANVRAGE8401258,A NL188406C (nl) 1983-04-18 1984-04-18 N-gesubstitueerde fenethanolamineverbinding met stimulerende werking op betaŸ2-adrenoreceptoren en farmaceutisch preparaat daarvan.
BE0/213843A BE900835R (fr) 1983-04-18 1984-10-17 Derives de phenethanol-amine.
ES539625A ES8609209A1 (es) 1983-04-18 1985-01-16 Un procedimiento para la preparacion de derivados de fenetano.
GB08612357A GB2176476B (en) 1983-04-18 1986-05-21 Phenethanolamine derivatives
AR87306841A AR245687A1 (es) 1983-04-18 1987-02-25 Un procedimiento para la preparacion del compuesto 4-hidroxi-alfa(1) 6-4- (fenilbutoxi)hexil-amino-metil-1,3-bencenedimetanol
MYPI87002277A MY102087A (en) 1983-04-18 1987-09-29 Phenethanolamine derivatives.
JP63043277A JPS63264443A (ja) 1983-04-18 1988-02-25 フェネタノールアミン誘導体
AR89313169A AR247721A1 (es) 1983-04-18 1989-02-08 Un procedimiento para la preparacion de compuestos de fenetanolamina y sus sales y solvatos farmaceuticamente aceptables
KE3864A KE3864A (en) 1983-04-18 1989-02-17 Phenethanolamine derivatives
SG122/89A SG12289G (en) 1983-04-18 1989-02-24 Phenethanolamine derivatives
HK368/89A HK36889A (en) 1983-04-18 1989-05-04 Phenethanolamine derivatives
US07/397,664 US4992474A (en) 1983-04-18 1989-08-23 Phenethanolamine derivatives
CY1482A CY1482A (en) 1983-04-18 1989-12-08 Phenethanolamine derivatives
US07/541,631 US5091422A (en) 1983-04-18 1990-06-21 Phenethanolamine derivatives
US07/619,899 US5126375A (en) 1983-04-18 1990-11-29 Phenethanolamine derivatives
US07/810,183 US5243076A (en) 1983-04-18 1991-12-19 Phenethanolamine derivatives
SK4028-91A SK278120B6 (en) 1983-04-18 1991-12-23 Phenethanolamine derivatives and pharmaceutical compositions containing them
CS914028A CZ285602B6 (cs) 1983-04-18 1991-12-23 Fenethanolaminové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem
US07/837,783 US5225445A (en) 1983-04-18 1992-02-19 Phenethanolamine derivatives having β2 -adrenoreceptor selective stimulant action
MX9203226A MX9203226A (es) 1983-04-18 1992-06-24 Derivados de fenetanolamina y composicion farmaceutica que los contiene.
CA000616467A CA1336004C (en) 1983-04-18 1992-08-18 Phenethanolamine derivatives
JP4219484A JPH0729997B2 (ja) 1983-04-18 1992-08-18 フェニルアルコキシ誘導体
DK199201580A DK175083B1 (da) 1983-04-18 1992-12-30 Aminderivater, som kan anvendes til fremstilling af phenethanolaminforbindelser
NL930066C NL930066I2 (nl) 1983-04-18 1993-06-11 N-gesubstitueerde fenethanolamineverbinding met stimulerende werking op beta2-adrenoreceptoren en farmaceutisch preparaat daarvan.
BG98059A BG61490B2 (bg) 1983-04-18 1993-08-20 Фенетаноламинови производни
EC1994001094A ECSP941094A (es) 1983-04-18 1994-05-26 Derivados de fenetanolamina
NO1994017C NO1994017I1 (no) 1983-04-18 1994-09-22 Salmeterol/ (RS)-5-(1-hydroksy-2-(6-(4-fenylbutoksy)heksylamino)-etyl)-salicylalkohol (generisk vavn Salmeterol) og dens salter og solvater innebefattet 1-hydroksy-2-naftalenkarboksylatet (hydroksynaftoat) (xinafoat)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838310477A GB8310477D0 (en) 1983-04-18 1983-04-18 Chemical compounds

Publications (1)

Publication Number Publication Date
GB8310477D0 true GB8310477D0 (en) 1983-05-25

Family

ID=10541275

Family Applications (1)

Application Number Title Priority Date Filing Date
GB838310477A Pending GB8310477D0 (en) 1983-04-18 1983-04-18 Chemical compounds

Country Status (5)

Country Link
JP (1) JPS59199659A (ja)
BE (1) BE900835R (ja)
EC (1) ECSP941094A (ja)
GB (1) GB8310477D0 (ja)
ZA (1) ZA842875B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95542B (pt) * 1989-10-10 1999-09-30 Glaxo Group Ltd Processo para a prparacao de derivados de fenetanolamina
WO2003024452A1 (de) * 2001-09-14 2003-03-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittel zur inhalation
JP2005519110A (ja) * 2002-03-04 2005-06-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規なケイ皮酸塩、その調製方法及び医薬品としての使用
WO2004037807A2 (en) * 2002-10-22 2004-05-06 Glaxo Group Limited Medicinal arylethanolamine compounds
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
GB0329182D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
ES2265276B1 (es) * 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Also Published As

Publication number Publication date
ZA842875B (en) 1985-02-27
ECSP941094A (es) 1995-01-16
BE900835R (fr) 1985-04-17
JPS59199659A (ja) 1984-11-12
JPH03858B2 (ja) 1991-01-09

Similar Documents

Publication Publication Date Title
AR244199A1 (es) Procedimiento para preparar derivados de fenetanolamina y sus sales y solvatos farmaceuticamente aceptables.
GB8313571D0 (en) Chemical compounds
GB8332435D0 (en) Chemical compounds
GB8318833D0 (en) Chemical compounds
GB8332437D0 (en) Chemical compounds
GB8328757D0 (en) Chemical compounds
GB8310477D0 (en) Chemical compounds
GB8332091D0 (en) Chemical compounds
GB8327966D0 (en) Chemical compounds
GB8328907D0 (en) Chemical compounds
GB8308615D0 (en) Chemical compounds
PT78851A (en) Chemical compounds
GR81105B (en) Chemical compounds
GB8300721D0 (en) Chemical compounds
GB8332436D0 (en) Chemical compounds
GB8331718D0 (en) Chemical compounds
GB8300720D0 (en) Chemical compounds
GB8334312D0 (en) Chemical compounds
GB8332195D0 (en) Chemical compounds
GB8325263D0 (en) Chemical compounds
GB8305448D0 (en) Chemical compounds
GB8331717D0 (en) Chemical compounds
GB8317087D0 (en) Chemical compounds
GB8332203D0 (en) Chemical compounds
GB8318832D0 (en) Chemical compounds